NASDAQ: SBRASabra Health Care Reit Inc Stock
$18.21-0.04 (-0.22%)
Updated Oct 23, 2025
SBRA Price
$18.21
Fair Value Price
$52.19
Market Cap
$4.37B
52 Week Low
$15.60
52 Week High
$20.03
P/E
23.35x
P/B
1.61x
P/S
5.99x
PEG
0.9x
Dividend Yield
4.94%
Revenue
$733.04M
Earnings
$182.33M
Gross Margin
100%
Operating Margin
40.32%
Profit Margin
24.9%
Debt to Equity
0.97
Operating Cash Flow
$339M
Beta
0.6
Next Earnings
Oct 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SBRA Overview
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SBRA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
SBRA
Ranked#6 of 17
Ranked#6 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.61 | B | |
| $34.93 | C | |
| $69.96 | C |
Be the first to know about important SBRA news, forecast changes, insider trades & much more!
SBRA News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SBRA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SBRA ($18.21) is undervalued by 65.11% relative to our estimate of its Fair Value price of $52.19 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SBRA ($18.21) is significantly undervalued by 65.11% relative to our estimate of its Fair Value price of $52.19 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SBRA ($18.21) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SBRA due diligence checks available for Premium users.
Valuation
SBRA fair value
Fair Value of SBRA stock based on Discounted Cash Flow (DCF)
Price
$18.21
Fair Value
$52.19
Undervalued by
65.11%
SBRA ($18.21) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SBRA ($18.21) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SBRA ($18.21) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SBRA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.35x
Industry
80.5x
Market
38.83x
SBRA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SBRA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SBRA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.61x
Industry
2.49x
SBRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SBRA price to earnings growth (PEG)
For valuing profitable companies with growth potential
SBRA is good value based... subscribe to Premium to read more.
PEG Value Valuation
SBRA's financial health
Profit margin
Revenue
$189.2M
Net Income
$65.5M
Profit Margin
34.7%
SBRA's Earnings (EBIT) of $295.55M... subscribe to Premium to read more.
Interest Coverage Financials
SBRA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.3B
Liabilities
$2.6B
Debt to equity
0.97
SBRA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SBRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$81.0M
Investing
-$45.1M
Financing
$36.7M
SBRA's operating cash flow ($338.84M)... subscribe to Premium to read more.
Debt Coverage Financials
SBRA vs Healthcare Facility REIT Stocks
Sabra Health Care Reit Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.